Log in to save to my catalogue

Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relaps...

Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relaps...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4411183

Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing– remitting multiple sclerosis

About this item

Full title

Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing– remitting multiple sclerosis

Publisher

London, England: SAGE Publications

Journal title

Multiple sclerosis, 2013-11, Vol.19 (13), p.1726-1733

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Background and objective:
Acute disseminated encephalomyelitis (ADEM) and relapsing–remitting multiple sclerosis (RRMS) share overlapping clinical, radiologic and laboratory features at onset. Because autoantibodies may contribute to the pathogenesis of both diseases, we sought to identify autoantibody biomarkers that are capable of distinguishi...

Alternative Titles

Full title

Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing– remitting multiple sclerosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4411183

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4411183

Other Identifiers

ISSN

1352-4585

E-ISSN

1477-0970

DOI

10.1177/1352458513485653

How to access this item